Opioid-Induced Constipation Treatment Market: By Drug Type, By Formulation Type, By Administration, By Distribution Channel and Region Forecast 2019-2030

Opioid-Induced Constipation Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Type (Peripherally restricted-opioid receptor antagonists, Non-selective opioid antagonists, Locally acting chloride channel activators), By Formulation Type (Solids, Semi-solids, Liquids), By Administration (Oral, Parenteral), By Distribution Channel (Drugstore, Retail pharmacies, Hospital pharmacies) and Region Forecast 2019-2030

Opioid Induced Constipation Treatment Market size was valued at US$ 2911.97 million in 2023 and is poised to grow at a CAGR of 4.7% from 2024-2030. Global market are the drugs used for its pain relieving properties in non-cancer and chronic kidney diease (ckd) drugs pain. The adverse effects associated with the opioids are decreasing gastrointestinal tracts motility, making patients strain, and making of solid discharges.

Furthermore, long-term use of opioids cause harm to the sensory system, limits the release of endogenous opioids such as endorphins. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The symptoms associated with the opioid-induced constipation are included dry and hard tools, leathery feeling, painful defecation, bulged abdomen, and loss of appetite. The market growing at a significant CAGR due to rise in the aging population using opioid analgesics for chronic pains. Increase in the illicit use of medications, prolonged usage of opioids in the treatment of pain, an increase in the prevalence of cancer is anticipated to boost the global Opioid-Induced Constipation Treatment Market.

Furthermore, launching of newer drugs, growing FDA approvals, positive outcomes in clinical trials, and rise in the healthcare expenditure are expected to propel the market over the forecast period. However, lack of awareness regarding opioid induced constipation in patients, the absence of treatment innovations, a high cost of newer pharmaceuticals, adverse effects, including nausea, a risk of heart problems and strokes associated with these drugs and unfavorable reimbursement policies expected to hamper the growth of the market.

This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Global Opioid Induced Constipation Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.7%

Largest Market

North-America

Fastest Growing Market

Asia Pacific

Opioid Induced Constipation Treatment Market Dynamics

Opioid-induced constipation is becoming increasingly common. In 2013, the American Academy of Pain Medicine (AAPM) estimated that about 100 million individuals in the United States experienced opioid-induced constipation. Furthermore, the AAPM predicted that the number of instances would increase as the number of people using opioids increased. There is a rising awareness of the availability of a wide range of opioid medications. Patients will be more likely to use these medications to treat chronic pain as a result of this. The growing number of people suffering from opioid-induced constipation, particularly in North America, is expected to propel the total opioid-induced constipation treatment business forward. Because of the enormous number of persons who take opioid medicines, the regional market is expected to increase at a significant rate. This is due to the high prevalence of chronic pain-related diseases in this area.

Global Opioid Induced Constipation Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2911.97 million

Market CAGR

4.7%

By Drug Type

  • Peripherally restricted opioid receptor antagonists
  • Non-selective opioid antagonists
  • Opioid receptor antagonists
  • Locally acting chloride channel activators

By Formulation Type

  • Solids
  • Semi-solids
  • Liquids

By Distribution Channel

  • Drugstore
  • Retail pharmacies
  • Hospital pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The opioid induced constipation treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis 

Download Free Sample Report

Frequently Asked Questions

The opioid-induced constipation treatment market size is valued at US$ 2911.97 million in 2023 and is poised to grow at a CAGR of 4.7% from 2024-2030.

Rise in the Availability of Effective OIC Drugs Along with Growing Prevalence of Chronic Idiopathic Pains

Europe is the fastest-growing for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Opioid Induced Constipation Treatment Market Introduction 
2.1.Global Opioid Induced Constipation Treatment Market  - Taxonomy
2.2.Global Opioid Induced Constipation Treatment Market  - Definitions
2.2.1.Drug Type
2.2.2. Formulation Type
2.2.3.Distribution Channel
2.2.4.Region
3.Global Opioid Induced Constipation Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Opioid Induced Constipation Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Opioid Induced Constipation Treatment Market  By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Peripherally restricted ?-opioid receptor antagonists
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Non-selective opioid antagonists
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. ? -opioid receptor antagonists
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Locally acting chloride channel activators
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Opioid Induced Constipation Treatment Market  By  Formulation Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Solids
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Semi-solids
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Liquids
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Opioid Induced Constipation Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Drugstore
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail pharmacies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Hospital pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Opioid Induced Constipation Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Opioid Induced Constipation Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Peripherally restricted ?-opioid receptor antagonists
9.1.2.Non-selective opioid antagonists
9.1.3.? -opioid receptor antagonists
9.1.4.Locally acting chloride channel activators
9.2.   Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Solids
9.2.2.Semi-solids
9.2.3.Liquids
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Drugstore
9.3.2.Retail pharmacies
9.3.3.Hospital pharmacies
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Opioid Induced Constipation Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Peripherally restricted ?-opioid receptor antagonists
10.1.2.Non-selective opioid antagonists
10.1.3.? -opioid receptor antagonists
10.1.4.Locally acting chloride channel activators
10.2.   Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Solids
10.2.2.Semi-solids
10.2.3.Liquids
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Drugstore
10.3.2.Retail pharmacies
10.3.3.Hospital pharmacies
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Opioid Induced Constipation Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Peripherally restricted ?-opioid receptor antagonists
11.1.2.Non-selective opioid antagonists
11.1.3.? -opioid receptor antagonists
11.1.4.Locally acting chloride channel activators
11.2.   Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Solids
11.2.2.Semi-solids
11.2.3.Liquids
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Drugstore
11.3.2.Retail pharmacies
11.3.3.Hospital pharmacies
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Opioid Induced Constipation Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Peripherally restricted ?-opioid receptor antagonists
12.1.2.Non-selective opioid antagonists
12.1.3.? -opioid receptor antagonists
12.1.4.Locally acting chloride channel activators
12.2.   Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Solids
12.2.2.Semi-solids
12.2.3.Liquids
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Drugstore
12.3.2.Retail pharmacies
12.3.3.Hospital pharmacies
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Opioid Induced Constipation Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Peripherally restricted ?-opioid receptor antagonists
13.1.2.Non-selective opioid antagonists
13.1.3.? -opioid receptor antagonists
13.1.4.Locally acting chloride channel activators
13.2.   Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Solids
13.2.2.Semi-solids
13.2.3.Liquids
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Drugstore
13.3.2.Retail pharmacies
13.3.3.Hospital pharmacies
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.GlaxoSmithKline plc (U.K.)
14.2.2.AstraZeneca U.K)
14.2.3.Pfizer Inc. (U.S.)
14.2.4.SLA Pharma AG (U.K.)
14.2.5.AIKO Biotechnology, Inc. (U.S.)
14.2.6.Cubist Pharmaceuticals (Merck & Co. Inc.,) (U.S.)
14.2.7.Takeda Pharmaceutical Company Limited (Japan)
14.2.8.Boehringer Ingelheim GmbH (Germany)
14.2.9.Bayer AG (Germany)
14.2.10.Valeant (Canada)
14.2.11.Abbott Laboratories (U.S.)
14.2.12.Purdue Pharma LP (U.S.)
14.2.13.Shionogi Inc. (U.S.)
14.2.14.Cosmo Pharmaceuticals  N.V. (Ireland)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • GlaxoSmithKline plc (U.K.)
  • AstraZeneca U.K)
  • Pfizer Inc. (U.S.)
  • SLA Pharma AG (U.K.)
  • AIKO Biotechnology, Inc. (U.S.)
  • Cubist Pharmaceuticals (Merck & Co. Inc.,) (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Boehringer Ingelheim GmbH (Germany)
  • Bayer AG (Germany)
  • Valeant (Canada)
  • Abbott Laboratories (U.S.)
  • Purdue Pharma LP (U.S.)
  • Shionogi Inc. (U.S.)
  • Cosmo Pharmaceuticals  N.V. (Ireland)

Related Industry Reports